J Korean Med Sci.  2005 Jun;20(3):417-420. 10.3346/jkms.2005.20.3.417.

Prognostic Factors of Response to Laparoscopic Splenectomy in Patients with Idiopathic Thrombocytopenic Purpura

• Kwon HC
• Moon CH
• Cho YR
• Kim MC
• Kim KH
• Han JY
• Lee YH
• Oh SY
• Kim SH
• Kim JS
• Kim HJ

• KMID: 1778499
• DOI: http://doi.org/10.3346/jkms.2005.20.3.417

Abstract

Laparoscopic splenectomy (LS) has become the treatment of choice for patients with idiopathic thrombocytopenic purpura (ITP) who do not respond to medical treatment. The aim of this study was to identify factors predictive of outcome after LS for ITP. From May 1997 to December 2002, we performed 30 LS on patients with ITP. A positive response was defined as a postoperative platelet count greater than 50,000/microliter and no requirement for maintenance therapy. Chi-square testing was performed to determine the predictive effects of the following variables: age, sex, preoperative response to steroids or immunoglobulin, duration of disease, antiplatelet antibody, platelet associated antibody, and antinuclear antibody. LS was successfully performed in all patients. For a mean follow-up interval of 24.3 months, response to LS was 73.3%. Splenectomy for steroid nonresponders resulted in an inferior complete response rate (10 of 18, 55.6%) as compared with those that experienced relapse after steroid treatment (11 of 12, 91.7%) (p=0.042). The other significant predictor of outcome by univariate analysis was the time between diagnosis and surgery (p=0.049). The other variables showed no significant correlation with successful splenectomy. We conclude that LS can be performed safely with a satisfactory remission rate in patients with ITP who do not respond to medical treatment, and that the factors most frequently associated with surgical success are a response to steroid and disease duration.

Keyword

Purpura; Thrombocytopenic; Idiopathic; Laparoscopy; Splenectomy

MeSH Terms

Adolescent
Adult
Aged
Analysis of Variance
Chi-Square Distribution
Child
Child, Preschool
Female
Follow-Up Studies
Humans
Laparoscopy/methods
Male
Middle Aged
Platelet Count
Prognosis
Purpura, Thrombocytopenic, Idiopathic/*surgery
Splenectomy/*methods
Time Factors
Treatment Outcome

Reference

1. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002. 346:995–1008.

2. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenic purpura: a practice guideline developed by the explicit methods for the American Society of Hematology. Blood. 1996. 88:3–40.

3. Delaitre B, Maignien B. Laparoscopic splenectomy-technical aspects. Surg Endosc. 1992. 6:305–308.

4. Brunt LM, Langer JC, Quasebarth MA, Whitman ED. Comparative analysis of laparoscopic versus open splenectomy. Am J Surg. 1996. 172:596–601.

5. Watson DI, Coventry BJ, Chin T, Gill PG, Malycha P. Laparoscopic versus open splenectomy for immune thrombocytopenic purpura. Surgery. 1997. 121:18–22.

6. Szold A, Schwartz J, Abu-Abeid S, Bulvik S, Eldor A. Laparoscopic splenectomies for idiopathic thrombocytopenic purpura: experience of sixty cases. Am J Hematol. 2000. 63:7–10.

7. Pace DE, Chiasson PM, Schlachta CM, Mammazza J, Poulin EC. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura (ITP) Long term follow-up data. Surg Endosc. 2003. 17:95–98.

8. Kang JK, Lee WJ, Kim KS, Kim BR. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura. J Korean Surg Soc. 1996. 50:846–851.

9. Stanton CJ. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura (ITP). A five-year experience. Surg Endosc. 1999. 13:1083–1086.

10. Katkhouda N, Grant SW, Mavor E, Friedlander MH, Lord RV, Achanta K, Essani R, Mason R. Predictors of response after laparoscopic splenectomy for immune thrombocytopenic purpura. Surg Endosc. 2001. 15:484–488.

11. Duperier T, Brody F, Felsher J, Walsh RM, Rosen M, Ponsky J. Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura. Arch Surg. 2004. 139:61–66.

12. Wu JM, Lai IR, Yuan RH, Yu SC. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Am J Surg. 2004. 187:720–723.

13. Schwartz J, Leber MD, Gillis S, Giunta A, Eldor A, Bussel JB. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol. 2003. 72:94–98.

14. Lee WJ, Kim BR. Laparoscopic splenectomy for chronic idiopathic thrombocytopenic purpura. Surg Laparosc Endosc. 1997. 7:209–212.

15. Radaelli F, Faccini P, Goldaniga M, Guggiari E, Pozzoli E, Maiolo AT, Ciani A, Pogliani EM. Factors predicting response to splenectomy in adult patients with idiopathic thrombocytopenic purpura. Haematologica. 2000. 85:1040–1044.

16. Davis PW, Williams DA, Shamberger RC. Immune thrombocytopenia: surgical therapy and predictors of response. J Pediatr Surg. 1991. 26:407–412.

17. Jacir NN, Robertson FM, Crombleholme TM, Harris BH. Recurrence of immune thrombocytopenic purpura after splenectomy. J Pediatr Surg. 1996. 31:115–116.

18. Choi CW, Kim BS, Seo JH, Shin SW, Kim YH, Kim JS, Sohn SK, Kim JS, Shin DG, Ryoo HM, Lee KH, Lee JJ, Chung IJ, Kim HJ, Kwak JY, Yim CY, Ahn JS, Lee JA, Park YS. Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients. Am J Hematol. 2001. 66:197–202.

19. Fabris F, Tassan T, Ramon R, Carraro G, Randi ML, Luzzatto G, Moschino P, Girolami A. Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura. Br J Haematol. 2001. 112:637–640.

20. McMillan R, Durette C. Long-term outcomes in adults with chronic ITP after splenectomy failure. Blood. 2004. 104:956–960.

21. Andersen JC. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med. 1994. 330:1560–1564.